"Antidepressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
| Descriptor ID |
D000928
|
| MeSH Number(s) |
D27.505.954.427.700.122
|
| Concept/Terms |
Antidepressive Agents- Antidepressive Agents
- Agents, Antidepressive
- Antidepressant Drugs
- Drugs, Antidepressant
- Antidepressants
|
Below are MeSH descriptors whose meaning is more general than "Antidepressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antidepressive Agents".
This graph shows the total number of publications written about "Antidepressive Agents" by people in this website by year, and whether "Antidepressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 1 | 2 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 2 | 4 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 8 | 10 |
| 2006 | 5 | 3 | 8 |
| 2007 | 2 | 2 | 4 |
| 2008 | 6 | 4 | 10 |
| 2009 | 5 | 3 | 8 |
| 2010 | 4 | 4 | 8 |
| 2011 | 8 | 4 | 12 |
| 2012 | 6 | 3 | 9 |
| 2013 | 6 | 3 | 9 |
| 2014 | 5 | 4 | 9 |
| 2015 | 8 | 3 | 11 |
| 2016 | 6 | 1 | 7 |
| 2017 | 9 | 5 | 14 |
| 2018 | 9 | 7 | 16 |
| 2019 | 8 | 5 | 13 |
| 2020 | 6 | 12 | 18 |
| 2021 | 2 | 1 | 3 |
| 2022 | 2 | 16 | 18 |
| 2023 | 4 | 11 | 15 |
| 2024 | 10 | 3 | 13 |
| 2025 | 11 | 3 | 14 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antidepressive Agents" by people in Profiles.
-
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD). Int Clin Psychopharmacol. 2026 May 01; 41(3):184-191.
-
Combination of Antidepressants and Chemotherapeutic Agents to Overcome P-Glycoprotein-Mediated Resistance in Cancer Patients: A Systematic Review. Med Sci (Basel). 2026 Mar 07; 14(1).
-
Use of a Medication Management Algorithm in Depressed Youth Living with HIV: Secondary Analysis of a Multisite Randomized Controlled Trial. J Child Adolesc Psychopharmacol. 2026 Jan; 36(1):21-28.
-
Real-World Use, Effectiveness and Tolerability of Antidepressant Treatment in Oncology Patients. Psychooncology. 2025 Dec; 34(12):e70340.
-
A Practical Primer on How to Detect and Treat Depression in CKD. Am J Kidney Dis. 2026 Feb; 87(2):239-245.
-
Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group. Mol Psychiatry. 2025 Dec; 30(12):5625-5636.
-
Factors associated with initial medication adherence with first-line therapy for depression. J Affect Disord. 2025 Dec 15; 391:120004.
-
Examining Antidepressant Side Effect Burden in Youth: The FIBSER-C Scale in the Texas Youth Depression and Suicide Research Network Study. J Child Adolesc Psychopharmacol. 2025 Oct; 35(8):463-470.
-
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD). J Affect Disord. 2025 Dec 01; 390:119836.
-
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review. Int J Mol Sci. 2025 Jul 06; 26(13).